Heikki Seikkula

Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

Renato D. Lópes, Celestia S. Higano, Susan F. Slovin et al. · Circulation · 2021 · 143 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy

Kanerva Lahdensuo, Andrew Erickson, Irena Saarinen et al. · Modern Pathology · 2016 · 46 citations · Full text

Medicine, Oncology, Urology +14

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression

Irena Saarinen, Tuomas Mirtti, Heikki Seikkula et al. · PLoS ONE · 2015 · 42 citations · Full text

Medicine, Molecular Biology, Oncology +14

Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy

Lan Yu, Mervi Toriseva, Miikka Tuomala et al. · International Journal of Cancer · 2016 · 29 citations

Medicine, Oncology, Urology +17

New prostate cancer grade grouping system predicts survival after radical prostatectomy

Andrew Erickson, Kevin Sandeman, Kanerva Lahdensuo et al. · Human Pathology · 2018 · 26 citations · Full text

Medicine, Surgery, Urology +17